Physicians and clinical trial investigators are concerned that the Sunshine Act will have a negative effect on their practices, according to a recent study conducted by Industry Standard Research. Additionally, ISR found that 74% of physicians surveyed said they were not in favor of making data about industry-physician relationships public; others said they likely would reduce the amount of time they spend in group detail sessions after Sunshine Act implementation. "If physicians are concerned that interacting with the pharmaceuticals industry has a negative connotation, there could be a chilling effect on those relationships, which are vital to the public health," said Coalition for Healthcare Communication Executive Director John Kamp. "The Sunshine Act is supposed to lend transparency to these relationships, not undermine them," Kamp said. Read more.